Pharma wholesaler Salus sees H1 net profit edge down on higher revenues
Ljubljana, 31 August - Pharmaceuticals wholesaler Salus saw its sales revenues rise by 6.6% to EUR 107.8m in January-June compared to the same period last year. On the other hand, net profit edged down by 0.7% to EUR 1.85m, the company said in a press release published on the website of the Ljubljana Stock Exchange on Wednesday.
The rest of this news item is available to subscribers.
The news item consists of 662 characters (without spaces) or 135 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.